C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage

Kazumi Ikeda; Toshiaki Ikeda; Toshiaki Onizuka; Hiroo Terashi; Tadaharu Fukuda

doi:10.1186/cc976

journal article Dec 22, 2000

C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage

Kazumi Ikeda Toshiaki Ikeda

Toshiaki Onizuka Hiroo Terashi Tadaharu Fukuda

Critical Care Vol. 5 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1186/cc976

Topics

No keywords indexed for this article. Browse by subject →

References

20

[1]

Toshida K, Nakamura S, Watanabe H: Changes in coagulation -fibriolysis and cytokines of patients with subarachnoid hemorrhage. In Proceedings of the 13th Spasm Symposium; Kyoto. Edited by Mamio K. Tokyo: Tyuugaiigaku Co.,. 1997, 243-247.

[2]

Otsuka K, Suzuki Y, Takayasu M, Shibuya M, Yoshida J, Yamamoto N, Takahashi N: Changes of cytokine levels in sub-arachnoid hemorrhage and effect of cytokine on carine basilar artery. In Proceedings of the 12th Spasm Symposium; Kyoto. Edited by Saito I. Tokyo: Tyuugaiigaku Co.;. 1996, 234-237.

[3]

Suzuki M, Endo S, Inada K, Kudo A, Miura K, Kubo N, Kuroda K, Ogawa A: Increased levels of nitrite/ nitrate in the cerebrospinal fluid of patients with subarachnoid hemorrhage. In Proceedings of the 12th Spasm Symposium; Kyoto. Edited by Saito I. Tokyo: Tyuugaiigaku Co;. 1996, 234-238.

[4]

Suzuki Y: NO and cerebral vasospasm after subarachnoid hemorrhage. Clin Neurosci. 1998, 16: 87-89.

[5]

Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H: C-type natriuretic peptide in rats and humans. Endocrinology. 1991, 129: 1104-1106. 10.1210/endo-129-2-1104

[6]

Barr CS, Rhodes P, Struthers AD: C-type natriuretic peptide. Peptides. 1996, 17: 1243-1251. 10.1016/S0196-9781(96)00110-6. 10.1016/s0196-9781(96)00110-6

[7]

Neal F Kasseli, Gregory Helm, Nathan Simmons, Douglas P, Cail S: Treatment of cerebral vasospasm with intra arterial papaverine. J Neurosurg. 1992, 77: 848-852. 10.3171/jns.1992.77.6.0848

[8]

Hama N, Ito S, Nama N, Itoh H, Shirakawa S, Komatsu Y, Yoshimasu T, Tanaka I, Mori K, Nakao K: Detection of C-type Natriuretic Peptide in human circulation and marked increase of plasma CNP level in septic shock patient. Biochem Biophys Res Comm. 1994, 198: 1177-1182. 10.1006/bbrc.1994.1166. 10.1006/bbrc.1994.1166

[9]

Davidson NC, Barr CS, Struthers AD: C-type natriuretic peptide. Circulation. 1996, 93: 1155-1159. 10.1161/01.cir.93.6.1155

[10]

Cargill RI, Struthers AD, Lipworth BJ: Human C-type natriuretic peptide, effect on the hemodynamic and endocrine responses to angiotensin II. Cardiovasc Res. 1995, 29: 108-111. 10.1016/0008-6363(96)88554-3. 10.1016/0008-6363(96)88554-3

[11]

Barletta G, Lazzeri C, Vecchirino S, Delbene R, Messeri G, Shara D, Mannedi M: Low dose C-type natriuretic peptide does not affect cardiac and renal function in humans. Hypertension. 1998, 31: 802-808. 10.1161/01.hyp.31.3.802

[12]

Zhang LM, Castresana MR, McDonald MH, Johnson J, Newman W: Responses of human artery, vein, and cultured smooth muscle cells to atrial and C-type natriuretic peptides. Crit Care Med. 1996, 24: 306-313. 10.1097/00003246-199602000-00021. 10.1097/00003246-199602000-00021

[13]

Burnett JC: Coronary endothelial function in health and disease. Drugs. 1997, 53 (suppl): s22-s29.

[14]

Suga S, Ito H, Komatsu Y, Ogawa Y, Name N, Yoshimasa T, Nakao K: Cytokine induced CNP secretion from vascular endothelial cells. Endocrinology. 1993, 133: 3038-3041. 10.1210/endo.133.6.8243333

[15]

Suzuki Y, Otsuka K, Noda A, Tanazawa T, Takayasu M, Shibuya M, Yoshida J: Nitric oxide metabolism in the cisternal cerebral spinal fluid of the patients with subarachinoid hemorrhage. Neurosurgery. 1997, 41: 807-812. 10.1097/00006123-199710000-00008

[16]

Mori Y, Takayasu M, Suzuki Y, Shibuya M, Yoshida J, Hidaka H: Vasodilator effects of C-type natriuric peptide on cerebral arterioles in rat. Eur J Pharmacol. 1997, 320: 183-186. 10.1016/S0014-2999(96)00991-0. 10.1016/s0014-2999(96)00991-0

[17]

Ogawa Y, Nakao K, Nakagawa O, Komatsu Y, Hosoda K, Suga S, Arai H, Nagata K, Yoshida N, Imura H: Human C-type natriuretic peptide. Hypertension. 1992, 19: 809-813. 10.1161/01.hyp.19.6.809

[18]

Herman JP, Dolgas CM, Marcinek R: Expression and glucocorticoid regulation of natriuretic peptide clearance receptor (NPR-C) mRNA in rat brain and choroid-plexus. J Chem Neuroanat. 1996, 11: 257-265. 10.1016/S0891-0618(96)00170-6. 10.1016/s0891-0618(96)00170-6

[19]

Herman JP, Dolgas CM, Rucker D: Localization of natriuretic peptide activated guanylate cyclase mRNAs in the rat brain. J Comp Neurol. 1996, 369: 165-187. 10.1002/(SICI)1096-9861(19960527)369:2<165::AID-CNE1>3.0.CO;2-1. 10.1002/(sici)1096-9861(19960527)369:2<165::aid-cne1>3.0.co;2-1

[20]

Eelco FM, Schienvik WI, Burnett JC: Natriuretic peptide system and endothelium in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1997, 87: 275-280. 10.3171/jns.1997.87.2.0275

Metrics

15

Citations

20

References

Details

Published: Dec 22, 2000
Vol/Issue: 5(1)
License: View

Authors

Cite This Article

Kazumi Ikeda, Toshiaki Ikeda, Toshiaki Onizuka, et al. (2000). C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Critical Care, 5(1). https://doi.org/10.1186/cc976

C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage

You May Also Like